VALN - Valneva SE (VALN) CEO Thomas Lingelbach on Q1 2022 Results - Earnings Call Transcript

Valneva SE (VALN) Q1 2022 Earnings Conference Call May 5, 2022 10:00 AM ET Company Participants Thomas Lingelbach - Chief Executive Officer Peter Buhler - Chief Financial Officer Franck Grimaud - Chief Business Officer Conference Call Participants Samir Devani - Rx Securities Maury Raycroft - Jefferies Max Herrmann - Stifel Financial Corp. Evan Wang - Guggenheim Securities Jean-Jacques Le Fur - Bryan Garnier Franck Grimaud - Chief Business Officer Sebastiaan van der Schoot - Kempen & Company Presentation Thomas Lingelbach Good day, and welcome to our quarter one Financial Results and Corporate Update Call. Pleasure to be with you again today. Yeah. So basically, the quarter one has again been marked by excellent progress on our clinical programs. We have been able to report further positive Phase II results for our Lyme vaccine candidates, including quite exciting first pediatric data, first ever in the world of Lyme vaccine development. And

For further details see:

Valneva SE (VALN) CEO Thomas Lingelbach on Q1 2022 Results - Earnings Call Transcript